H.Lundbeck
Stock
Stock
ISIN: DK0061804770
Ticker: HLUN B
DK0061804770
HLUN B
Price
Price
CHART BY
Historical dividends and forecast
H.Lundbeck has so far distributed $0.179 in 2026. The next dividend will be paid on 23.03.2027
$0.463
CHART BY
Frequently asked questions
What is H.Lundbeck's market capitalization?
The market capitalization of H.Lundbeck is $6.46B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is H.Lundbeck's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for H.Lundbeck is 10.84. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for H.Lundbeck?
H.Lundbeck's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.601. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for H.Lundbeck's stock?
Currently, 15 analysts cover H.Lundbeck's stock, with a consensus target price of $7.501. Analyst ratings provide insights into the stock's expected performance.
What is H.Lundbeck's revenue over the trailing twelve months?
Over the trailing twelve months, H.Lundbeck reported a revenue of $3.94B.
What is the EBITDA for H.Lundbeck?
H.Lundbeck's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.44B. EBITDA measures the company's overall financial performance.
What is the free cash flow of H.Lundbeck?
H.Lundbeck has a free cash flow of $712.09M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does H.Lundbeck have, and what sector and industry does it belong to?
H.Lundbeck employs approximately 5,214 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of H.Lundbeck's shares?
The free float of H.Lundbeck is 268.92M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $6.46B
- EPS (TTM)
- $0.601
- Free Float
- 268.92M
- P/E ratio (TTM)
- 10.84
- Revenue (TTM)
- $3.94B
- EBITDA (TTM)
- $1.44B
- Free Cashflow (TTM)
- $712.09M
Pricing
- 1D span
- $6.485$6.621
- 52W span
- $5.567$7.458
Analyst Ratings
The price target is $7.501 and the stock is covered by 15 analysts.
Buy
6
Hold
7
Sell
2
Information
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
- Employees
- 5,214
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- DK0061804770
- Primary Ticker
- HLUN B
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet